| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.7M | — | +28.8% |
| Cost of Revenue | $2.3M | — | +31.5% |
| Gross Profit | $4.4M | — | +27.4% |
| R&D Expense | $606K | — | +11.6% |
| SG&A Expense | $2.8M | — | +23.7% |
| Operating Income | $1.0M | — | +52.6% |
| Pre-tax Income | $1.2M | — | +26.9% |
| Income Tax | $256K | — | +1070.0% |
| Net Income | $931K | — | +1.9% |
| EPS (Basic) | $0.08 | — | +0.0% |
| EPS (Diluted) | $0.08 | — | +0.0% |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $30.4M | +6.1% | +35.1% |
| Accounts Receivable | $3.8M | +1.4% | +12.7% |
| Inventory | $14.2M | +4.1% | +5.7% |
| Current Assets | $51.2M | +2.3% | +19.8% |
| Total Assets | $65.6M | +1.7% | +15.3% |
| Current Liabilities | $4.7M | -16.8% |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.5M | — | +130.2% |
| Capital Expenditures | $82K | — | -35.8% |
| Investing Cash Flow | -$105K | — | +22.0% |
| Free Cash Flow | $1.4M | — | +171.7% |
| +40.7% |
| Total Liabilities | $5.4M | -14.8% | +43.7% |
| Stockholders' Equity | $60.2M | +3.6% | +13.3% |